<DOC>
	<DOCNO>NCT00004005</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy , irinotecan , fluorouracil , leucovorin , work different way stop tumor cell divide stop grow die . Radiation therapy use high-energy x-rays damage tumor cell . Combining one chemotherapy drug radiation therapy may kill tumor cell . PURPOSE : This phase II trial study well give combination chemotherapy together radiation therapy work treat patient stage III stage IV colorectal carcinoma ( cancer ) , refractory carcinoma ( cancer ) , metastatic adenocarcinoma ( cancer ) unknown primary origin .</brief_summary>
	<brief_title>Irinotecan Followed By Fluorouracil Leucovorin Treating Patients With Stage III Stage IV Colorectal Carcinoma ( Cancer ) , Other Refractory Carcinoma , Metastatic Adenoma ( Cancer ) Unknown Primary Origin</brief_title>
	<detailed_description>OBJECTIVES : - Determine response rate patient stage IV colorectal carcinoma carcinoma treat irinotecan follow fluorouracil leucovorin calcium . - Determine disease-free survival patient stage III colorectal carcinoma , refractory carcinoma , metastatic adenocarcinoma unknown primary site treat regimen . - Determine toxicity regimen patient . OUTLINE : Patients stage III colorectal carcinoma ( post surgical resection ) receive irinotecan IV 1 hour day 1-5 day 8-12 . Treatment repeat every 3 week 2 course . Beginning week 7 , patient receive pelvic irradiation , leucovorin calcium IV 4 hour , fluorouracil IV 5-15 minute begin 1 hour leucovorin calcium infusion day 1-5 . Treatment repeat every 3 week total 2 course . Patients evidence disease may repeat 12-week block chemotherapy without pelvic irradiation 4 time 1 year . Patients stage IV colorectal carcinoma , refractory carcinoma , metastatic adenocarcinoma unknown primary site receive 12-week block chemotherapy ( irinotecan , fluorouracil , leucovorin calcium ) pelvic irradiation ( indicate ) . Pelvic irradiation patient unresected primary tumor undergo exploratory surgery 4-5 week completion radiotherapy , even absence visible tumor regression . Radical resection attempt effect local control control long term symptom related primary tumor . Patients complete response ( CR ) partial response ( PR ) chemotherapy surgery repeat 12-week block chemotherapy 3 time 1 year absence disease progression unacceptable toxicity . Patients CR PR chemotherapy response surgery receive irinotecan IV 1 hour day 1-5 day 8-12 every 3 week 1 year absence disease progression unacceptable toxicity . Patients stable disease ( SD ) progressive disease 2 course irinotecan SD , CR , PR surgery receive leucovorin calcium fluorouracil every 3 week 1 year absence disease progression unacceptable toxicity . Patients follow every 3 month 1 year every 6 month 3 year . PROJECTED ACCRUAL : A total 10 patient accrue study within 4 year .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Unknown Primary</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Camptothecin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : One follow diagnosis : Histologically prove previously untreated stage III stage IV colorectal carcinoma Other carcinomas refractory standard treatment Metastatic adenocarcinoma unknown primary site PATIENT CHARACTERISTICS : Age : Under 25 Performance status : ECOG 02 Life expectancy : At least 8 week Hematopoietic : Hemoglobin least 10.0 g/dL Absolute neutrophil count least 1,000/mm^3 Platelet count least 100,000/mm^3 Hepatic : Albumin great 3.0 g/dL Bilirubin le 1.5 mg/dL SGOT SGPT less 2 time normal Renal : Creatinine le 1.5 mg/dL OR Creatinine clearance great 80 mL/min Urinalysis normal Other : Blood glucose normal Electrolytes normal Prior curatively treat childhood cancer allow Weight great 10th percentile height Not pregnant nursing Negative pregnancy test PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy Not specify Radiotherapy Not specify Surgery Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>24 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>stage III colon cancer</keyword>
	<keyword>stage IV colon cancer</keyword>
	<keyword>stage III rectal cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
	<keyword>unspecified childhood solid tumor , protocol specific</keyword>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
	<keyword>adenocarcinoma unknown primary</keyword>
	<keyword>newly diagnose carcinoma unknown primary</keyword>
	<keyword>recurrent carcinoma unknown primary</keyword>
</DOC>